Literature DB >> 15817455

The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme.

Michael D Urbaniak1, Arthur Crossman, Tunhan Chang, Terry K Smith, Daan M F van Aalten, Michael A J Ferguson.   

Abstract

The de-N-acetylation of N-acetyl-D-glucosaminylphosphatidylinositol (GlcNAc-PI) is the second step of mammalian and trypanosomal glycosylphosphatidylinositol biosynthesis. Glycosylphosphatidylinositol biosynthesis is essential for Trypanosoma brucei, the causative agent of African sleeping sickness, and GlcNAc-PI de-N-acetylase has previously been validated as a drug target. Inhibition of the trypanosome cell-free system and recombinant rat GlcNAc-PI de-N-acetylase by divalent metal cation chelators demonstrates that a tightly bound divalent metal cation is essential for activity. Reconstitution of metal-free GlcNAc-PI de-N-acetylase with divalent metal cations restores activity in the order Zn(2+) > Cu(2+) > Ni(2+) > Co(2+) > Mg(2+). Site-directed mutagenesis and homology modeling were used to identify active site residues and postulate a mechanism of action. The characterization of GlcNAc-PI de-N-acetylase as a zinc metalloenzyme will facilitate the rational design of anti-protozoan parasite drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817455     DOI: 10.1074/jbc.M502402200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Catalysis by N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase (PIG-L) from Entamoeba histolytica: new roles for conserved residues.

Authors:  Mohammad Ashraf; Perinthottathil Sreejith; Usha Yadav; Sneha Sudha Komath
Journal:  J Biol Chem       Date:  2013-01-22       Impact factor: 5.157

Review 2.  Lipid metabolism in Trypanosoma brucei.

Authors:  Terry K Smith; Peter Bütikofer
Journal:  Mol Biochem Parasitol       Date:  2010-04-09       Impact factor: 1.759

3.  N-acetyl-D-glucosaminylphosphatidylinositol de-N-acetylase from Entamoeba histolytica: metal alters catalytic rates but not substrate affinity.

Authors:  Mohammad Ashraf; Bhawna Yadav; Sreejith Perinthottathil; Kokila Sree Kumar; Divya Vats; Rohini Muthuswami; Sneha Sudha Komath
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

4.  Drug targets in Leishmania.

Authors:  Bhavna Chawla; Rentala Madhubala
Journal:  J Parasit Dis       Date:  2010-10-08

5.  GlcNAc De-N-Acetylase from the Hyperthermophilic Archaeon Sulfolobus solfataricus.

Authors:  Roberta Iacono; Andrea Strazzulli; Luisa Maurelli; Nicola Curci; Angela Casillo; Maria Michela Corsaro; Marco Moracci; Beatrice Cobucci-Ponzano
Journal:  Appl Environ Microbiol       Date:  2019-01-09       Impact factor: 4.792

Review 6.  Targeting the GPI biosynthetic pathway.

Authors:  Usha Yadav; Mohd Ashraf Khan
Journal:  Pathog Glob Health       Date:  2018-02-27       Impact factor: 2.894

Review 7.  Biosynthesis and functions of mycothiol, the unique protective thiol of Actinobacteria.

Authors:  Gerald L Newton; Nancy Buchmeier; Robert C Fahey
Journal:  Microbiol Mol Biol Rev       Date:  2008-09       Impact factor: 11.056

Review 8.  Trypanosome glycosylphosphatidylinositol biosynthesis.

Authors:  Yeonchul Hong; Taroh Kinoshita
Journal:  Korean J Parasitol       Date:  2009-08-28       Impact factor: 1.341

9.  Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma species.

Authors:  Erofili Giannakopoulou; Vasiliki Pardali; Efseveia Frakolaki; Vasileios Siozos; Vassilios Myrianthopoulos; Emmanuel Mikros; Martin C Taylor; John M Kelly; Niki Vassilaki; Grigoris Zoidis
Journal:  Medchemcomm       Date:  2019-05-16       Impact factor: 3.597

10.  Inhibitors incorporating zinc-binding groups target the GlcNAc-PI de-N-acetylase in Trypanosoma brucei, the causative agent of African sleeping sickness.

Authors:  Nuha Z Abdelwahab; Arthur T Crossman; Lauren Sullivan; Michael A J Ferguson; Michael D Urbaniak
Journal:  Chem Biol Drug Des       Date:  2012-03       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.